Cartesian Therapeutics’ Dr. Metin Kurtoglu joins Cell & Gene: The Podcast to explain their autologous RNA cell therapies, Descartes-08 for Myasthenia Gravis and Descartes-11 for multiple myeloma. He also sheds light on Descartes-25, their allogeneic RNA cell therapy, and the reasons for the move to “off-the-shelf.” Hear why the future of RNA cell therapy is not confined to rare and fatal diseases and subscribe so you never miss an episode!
What You’ll Learn
How to enter and move between academia, biotech and big pharma
Tips for advancing your career internally, even in the most competitive environments
How to discover your zone of genius and things to consider when trying to identify your next career move
Your personal brand, why it matters, and how to get noticed
The culture of the industry, including progress made in diversity, equity, and inclusion but also challenges of working in an industry that lacks leadership diversity. We have a candid conversation on the barriers to leadership and how to make progress toward a truly inclusive and equitable industry.
Everything you Need to Know about COVID-19 with Dr. Collins Jones (Podcast) Covering everything from the virus, to protection and testing, Dr. Jones shares the science of COVID-19 for non-scientists [….]